Estradiol butyrylacetate/testosterone ketolaurate/reserpine

http://dbpedia.org/resource/Estradiol_butyrylacetate/testosterone_ketolaurate/reserpine an entity of type: Thing

Estradiol butyrylacetate/testosterone ketolaurate/reserpine (EBA/TKL/R), sold under the brand name Klimanosid R-Depot, is an injectable combination medication of estradiol butyrylacetate (EBA), an estrogen, testosterone ketolaurate (TKL; testosterone caprinoylacetate), an androgen/anabolic steroid, and reserpine, an antipsychotic, which was previously used in menopausal hormone therapy for women, particularly in those with pronounced neurovegetative symptoms. It contains 2 mg EBA, 50 mg TKL, and 0.4 mg reserpine in oil solution in each 1 mL ampoule and is administered by intramuscular injection at regular intervals. The medication was marketed in 1957. rdf:langString
rdf:langString Estradiol butyrylacetate/testosterone ketolaurate/reserpine
rdf:langString Estradiol butyrylacetate /
rdf:langString testosterone ketolaurate
xsd:integer 60997926
xsd:integer 984355882
rdf:langString Estradiol butyrylacetate and
rdf:langString Estradiol butyrylacetate
rdf:langString Reserpine
rdf:langString Testosterone ketolaurate
rdf:langString Estradiol butyrylacetate /
rdf:langString testosterone ketolaurate
rdf:langString Testosterone ketolaurate.svg
rdf:langString EBA/TKL; EBA/TCA
rdf:langString Klimanosid R-Depot
rdf:langString combo
xsd:integer 235 250
rdf:langString Estradiol butyrylacetate/testosterone ketolaurate/reserpine (EBA/TKL/R), sold under the brand name Klimanosid R-Depot, is an injectable combination medication of estradiol butyrylacetate (EBA), an estrogen, testosterone ketolaurate (TKL; testosterone caprinoylacetate), an androgen/anabolic steroid, and reserpine, an antipsychotic, which was previously used in menopausal hormone therapy for women, particularly in those with pronounced neurovegetative symptoms. It contains 2 mg EBA, 50 mg TKL, and 0.4 mg reserpine in oil solution in each 1 mL ampoule and is administered by intramuscular injection at regular intervals. The medication was marketed in 1957. EBA/TKL reportedly has a duration of about 21 days. Oral tablet products with the same brand names of Klimanosid and Klimanosid R, containing methylestradiol and methyltestosterone, with and without reserpine, were marketed around the same time as Klimanosid-R Depot, and should not be confused with the injectable formulation.
xsd:nonNegativeInteger 6787
rdf:langString Klimanosid R-Depot

data from the linked data cloud